Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2000, for On Assignment, Inc. (Note: The input metadata lists "Everforth Inc," but the filing text explicitly identifies the registrant as On Assignment, Inc.). The company operates in two reportable segments: Lab Support (laboratory and scientific professionals) and Healthcare Staffing (medical billing and staffing). The financial statements reflect a retroactive restatement due to a two-for-one stock split authorized on March 7, 2000.
Key Financial Metrics
| Metric | Q1 2000 | Q1 1999 |
|---|---|---|
| Revenues | $44,345,000 | $34,789,000 |
| Gross Profit | $14,446,000 | $11,220,000 |
| Operating Income | $6,256,000 | $4,429,000 |
| Net Income | $4,206,000 | $3,030,000 |
| Diluted EPS | $0.19 | $0.13 |
| Cash from Operations | $5,673,000 | $6,059,000 |
| Cash and Equivalents (End of Period) | $34,583,000 | $33,366,000 |
| Total Assets | $81,605,000 | $71,740,000 |
| Total Liabilities | $9,245,000 | $8,293,000 |
Margins: Gross margin was 32.6% in Q1 2000 compared to 32.3% in Q1 1999. Operating margin improved to 14.1% from 12.7%.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 27.5% year-over-year, driven by growth in both segments. Healthcare Staffing revenue rose to $12.27M (from $7.75M), and Lab Support revenue rose to $32.08M (from $27.04M).
- Profitability: Net income increased 38.8% to $4.21M. Operating expenses grew 20.6% but decreased as a percentage of revenue from 19.5% to 18.5% due to operational leverage.
- Cash Flow: Operating cash flow decreased slightly to $5.67M (from $6.06M) primarily due to a $1.62M increase in accounts receivable. However, financing activities provided a significant $3.71M, largely from stock option exercises ($3.58M).
- Segment Shifts: The Lab Support segment's cost of services as a percentage of revenue improved (67.8% to 67.2%), while the Healthcare Staffing segment's cost ratio worsened slightly (67.4% to 67.9%).
Guidance, Outlook, and Risks
- Outlook: Management believes current cash balances, operating funds, and borrowing ability are sufficient to meet requirements for the next 12 months. No specific numerical guidance for future quarters was provided in this text.
- Stock Split: A two-for-one stock split was effected on April 3, 2000. All share and per-share data in the filing have been retroactively restated.
- Stock Repurchase: The company has a program to repurchase up to $15M of common stock. As of March 31, 2000, $7.81M had been utilized to repurchase 660,000 shares.
- Risks: Key risks include the ability to attract and retain qualified account managers and temporary employees, management of growth in international markets, and integration of acquired operations. The company notes that results for the quarter are not necessarily indicative of full-year results.
- Market Risk: Exposure to interest rate and foreign currency fluctuations is considered not significant due to short maturities of investments and the relative size of foreign operations.
Investor Verification Checklist
- Verify the impact of the two-for-one stock split on share counts and EPS calculations in subsequent filings.
- Monitor the increase in accounts receivable ($1.62M increase in the quarter) to ensure collection trends remain healthy.
- Review the decline in EnviroStaff division revenues within the Lab Support segment to assess the success of the transition away from remediation business.
- Track the remaining capacity under the $15M stock repurchase program (approx. $7.2M remaining).
- Confirm the sustainability of the Healthcare Staffing segment's cost of services ratio, which increased slightly in the quarter.